Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Utilizing Escitalopram to Address Cognitive Dysfunction in Glioma Patients

NCT03728673 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT03728673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03728673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Utilizing Escitalopram to Address Cognitive Dysfunction in Glioma Patients
Lead sponsor
University of Nebraska
Phase
Phase 2
Overall status
Recruiting
Start date
March 6, 2019
Completion date
June 30, 2029
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, glioma of brain